Gunnar Casserstedt
Président chez KD Incentive AB
Profil
Gunnar Casserstedt is currently the Chairman at KD Incentive AB.
Previously, he was the Deputy Chief Executive Officer & Executive VP at Karolinska Development AB, Chairman at KCIF Fund Management AB, Director at Neurotherapeutics AB and Modus Therapeutics Holding AB, and Chief Financial Officer at Sopherion Therapeutics LLC.
He also served as the Chief Financial Officer at Karolinska Development AB (Private Equity) from 2006 to 2012 and as the Vice President-Finance, Research & Development at Pharmacia, Inc.
Postes actifs de Gunnar Casserstedt
| Sociétés | Poste | Début |
|---|---|---|
| KD Incentive AB | Président | - |
Anciens postes connus de Gunnar Casserstedt
| Sociétés | Poste | Fin |
|---|---|---|
Neurotherapeutics AB
 Neurotherapeutics AB Miscellaneous Commercial ServicesCommercial Services Neurotherapeutics AB researches and develops pharmaceutical products. It identifies and delivers stem cell-based therapies for Parkinson's disease. The company was founded in 2003 by Ernest Arenas and is headquartered in Stockholm, Sweden. | Directeur/Membre du Conseil | 19/01/2012 |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Directeur Financier/CFO | 01/01/2012 |
| MODUS THERAPEUTICS HOLDING AB | Directeur/Membre du Conseil | - |
| KCIF Fund Management AB | Président | - |
Sopherion Therapeutics LLC
 Sopherion Therapeutics LLC BiotechnologyHealth Technology Sopherion Therapeutics LLC develops and commercializes anti-cancer therapies. The company was founded by Ronald H. Goldfarb and Salvatore Forenza in 2002 and is headquartered in Princeton, NJ. | Directeur Financier/CFO | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| KAROLINSKA DEVELOPMENT AB | Finance |
| MODUS THERAPEUTICS HOLDING AB | Health Technology |
| Entreprise privées | 6 |
|---|---|
Sopherion Therapeutics LLC
Sopherion Therapeutics LLC BiotechnologyHealth Technology Sopherion Therapeutics LLC develops and commercializes anti-cancer therapies. The company was founded by Ronald H. Goldfarb and Salvatore Forenza in 2002 and is headquartered in Princeton, NJ. | Health Technology |
Karolinska Development AB (Private Equity)
Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Finance |
| Pharmacia, Inc. | |
Neurotherapeutics AB
Neurotherapeutics AB Miscellaneous Commercial ServicesCommercial Services Neurotherapeutics AB researches and develops pharmaceutical products. It identifies and delivers stem cell-based therapies for Parkinson's disease. The company was founded in 2003 by Ernest Arenas and is headquartered in Stockholm, Sweden. | Commercial Services |
| KCIF Fund Management AB | |
| KD Incentive AB |
